We found significant enrichment between our Oligo.3 downregulated DEGs in E4+ carriers and their AD downregulated Oligo genes in E3/E4 vs. E3/E3 carriers, again including OPALIN and PLP1 (Fig S46C, Table S15). This evidence concerns the gene OPALIN and Alzheimer disease.